FAP

FOG-001 in Locally Advanced or Metastatic Solid Tumors

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors

Duodenal Polyposis Classification in FAP

Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease

From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19

Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

Video Capsule Examination in Patients With Lynch Syndrome

18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)

18F-FAPI PET in the Diagnosis of Liver Fibrosis

Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

Hereditary Colorectal and Associated Tumor Registry Study

Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA